JPRN-UMIN000015414已完成未知
Exploratory clinical study of first-line treatment for patients with advanced EGFR mutation-positive non-squamous non-small-cell lung cancer - Exploratory clinical study of first-line treatment for patients with advanced EGFR mutation-positive non-squamous non-small-cell lung cancer
Department of Thoracic Oncology Osaka Medical Center for Cardiovascular diseases0 个研究点目标入组 40 人开始时间: 2014年10月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.EGFR mutation Exon20 T790M positive 2.Symptomatic brain metastasis and a spinal metastases requiring surgical treatment or irradiation 3.Less than 5 years of disease-free interval with other malignancy 4.Pleural effusion, ascites or pericardial fluid in need of treatment 5.SVC syndrome 6.Spinal cord compression with symptoms 7.Cerebrovascular disorder with aymptoms 8.Unhealed fracture 9.Severe infection 10.Planned surgery during the study period 11.Obvious interstitial lung disease 12.Severe gastrointestinal disorder 13.Symptomatic corneal disease 14.Severe cardiac disease 15.Clinically significant drug allergy 16.Prior EGFR-TKI therapy 17.During pregnabcy or lactating woman 18.Uncontrolled psychiatric disease 19.Other
研究者
相似试验
进行中（未招募）
1 期
Clinical trial to investigate the efficacy of treatment combination with gemcitabine and pazopanib in patients with inoperable locally advanced or metastatic gallbladder and bile duct cancerInoperable locally advanced or metastatic cancer of the biliary tree (cholangiocarcinoma and gallbladder carcinoma)MedDRA version: 14.1Level: LLTClassification code 10017620Term: Gallbladder carcinomaSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10008593Term: CholangiocarcinomaSystem Organ Class: 100000004864MedDRA version: 14.1Level: LLTClassification code 10004655Term: Biliary carcinomaSystem Organ Class: 100000004864EUCTR2012-001705-24-GRHellenic Cooperative Oncology Group46
已完成
不适用
To study early treatment response in peripheral blood on Day 15 in B cell Acute Lymphoblastic Leukemia patientsCTRI/2016/08/007180Tata Memorial Hospital100
尚未招募
1 期
Clinical study for the first-line treatment of advanced hepatocellular carcinoma with anrotinib hydrochloride capsuleHepatocellular carcinomaITMCTR1900002329Guilin Traditional Chinese Medicine Hospital
已完成
不适用
The clinical study for evaluating the early efficacy and safty of alpha-1-adrenoreceptor antagonists in patient with benign prostatic hyperplasia.Benign prostatic hyperplasia (BPH)JPRN-UMIN000005151Department of Renal and Urologic Surgery, Asahikawa Medical University100
进行中（未招募）
1 期
Study of safety and efficacy of genome-edited hematopoietic stem and progenitor cells in sickle cell disease (SCD)EUCTR2019-003489-41-ITOVARTIS PHARMA AG30